Total Payments
$3,533
2024 Payments
$1,666
Companies
27
Transactions
125
Medicare Patients
1,264
Medicare Billing
$241,215
Payment Breakdown by Category
Food & Beverage$2,538 (71.8%)
Travel$995.53 (28.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,538 | 121 | 71.8% |
| Travel and Lodging | $995.53 | 4 | 28.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $1,078 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $598.29 | 35 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $383.59 | 19 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $306.39 | 20 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $203.34 | 5 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $178.30 | 6 | $0 (2024) |
| Philips Electronics North America Corporation | $129.44 | 6 | $0 (2023) |
| ABBVIE INC. | $111.69 | 1 | $0 (2023) |
| Amgen Inc. | $56.42 | 3 | $0 (2024) |
| Pinnacle Biologics, Inc | $53.24 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,666 | 28 | INTUITIVE SURGICAL, INC. ($1,078) |
| 2023 | $380.77 | 11 | ABBVIE INC. ($111.69) |
| 2022 | $154.52 | 7 | Boehringer Ingelheim Pharmaceuticals, Inc. ($46.52) |
| 2021 | $85.91 | 3 | BOSTON SCIENTIFIC CORPORATION ($35.28) |
| 2020 | $135.65 | 8 | GlaxoSmithKline, LLC. ($52.71) |
| 2019 | $290.66 | 17 | Boehringer Ingelheim Pharmaceuticals, Inc. ($88.90) |
| 2018 | $441.10 | 28 | GlaxoSmithKline, LLC. ($111.94) |
| 2017 | $378.96 | 23 | GlaxoSmithKline, LLC. ($186.16) |
All Payment Transactions
125 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $36.89 | General |
| Category: Narcoplepsy | ||||||
| 11/18/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $46.31 | General |
| Category: Narcoplepsy | ||||||
| 10/31/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $36.15 | General |
| Category: NEUROLOGY | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $36.15 | General |
| Category: NEUROLOGY | ||||||
| 07/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: RESPIRATORY | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Respiratory | ||||||
| 06/27/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Inflammation | ||||||
| 06/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: RESPIRATORY | ||||||
| 06/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $46.89 | General |
| Category: Narcoplepsy | ||||||
| 05/06/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: NEUROLOGY | ||||||
| 04/16/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $13.92 | General |
| Category: Medical Device | ||||||
| 03/26/2024 | Inari Medical, Inc. | CT THROMBECTOMY SYSTEM KIT (Device), FLOWTRIEVER CATHETER, S | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: VTE | ||||||
| 03/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: IMMUNOLOGY | ||||||
| 03/22/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $36.12 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 03/19/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Respiratory | ||||||
| 03/07/2024 | Cardinal Health 200 LLC | — | Food and Beverage | In-kind items and services | $22.00 | General |
| 03/05/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $65.49 | General |
| Category: SURGERY | ||||||
| 02/12/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: NEUROLOGY | ||||||
| 02/02/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $242.00 | General |
| Category: SURGERY | ||||||
| 02/02/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $231.86 | General |
| Category: SURGERY | ||||||
| 02/01/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: SURGERY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 410 | 521 | $150,044 | $60,673 |
| 2022 | 10 | 379 | 514 | $157,927 | $66,138 |
| 2021 | 7 | 306 | 530 | $177,539 | $73,421 |
| 2020 | 6 | 169 | 301 | $138,178 | $40,982 |
Total Patients
1,264
Total Services
1,866
Medicare Billing
$241,215
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 55 | 123 | $61,996 | $21,963 | 35.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 49 | $12,970 | $6,623 | 51.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 40 | 40 | $15,234 | $6,489 | 42.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 46 | 65 | $12,342 | $6,246 | 50.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 34 | $12,703 | $4,835 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 48 | $9,505 | $4,559 | 48.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 54 | $7,122 | $3,439 | 48.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $7,660 | $2,943 | 38.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $3,304 | $1,389 | 42.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 13 | 13 | $3,650 | $1,245 | 34.1% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 18 | 18 | $2,628 | $641.16 | 24.4% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 13 | 13 | $332.02 | $115.80 | 34.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 13 | 13 | $350.87 | $99.36 | 28.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 13 | 13 | $247.65 | $86.16 | 34.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 65 | 145 | $73,084 | $27,683 | 37.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 60 | 63 | $23,537 | $10,577 | 44.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 62 | 94 | $17,849 | $8,344 | 46.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 37 | $9,794 | $5,229 | 53.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 49 | $9,703 | $4,844 | 49.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 45 | 55 | $7,254 | $3,312 | 45.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $6,128 | $2,559 | 41.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $3,558 | $1,562 | 43.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 12 | 12 | $3,370 | $1,187 | 35.2% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 25 | 25 | $3,650 | $841.18 | 23.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 69 | 214 | $107,862 | $40,999 | 38.0% |
About Dr. Christopher Halpin, M.D
Dr. Christopher Halpin, M.D is a Pulmonary Disease healthcare provider based in Huntingdon Valley, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/06/2009. The National Provider Identifier (NPI) number assigned to this provider is 1326284787.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Halpin, M.D has received a total of $3,533 in payments from pharmaceutical and medical device companies, with $1,666 received in 2024. These payments were reported across 125 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,538).
As a Medicare-enrolled provider, Halpin has provided services to 1,264 Medicare beneficiaries, totaling 1,866 services with total Medicare billing of $241,215. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Huntingdon Valley, PA
- Active Since 01/06/2009
- Last Updated 06/25/2018
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326284787
Products in Payments
- Da Vinci Surgical System (Device) $1,078
- STIOLTO RESPIMAT (Drug) $254.19
- TRELEGY ELLIPTA (Drug) $229.40
- ANORO (Drug) $193.54
- WAKIX (Drug) $179.20
- XYWAV (Drug) $178.30
- SYMBICORT (Drug) $169.76
- DALVANCE (Drug) $111.69
- Respiratoriy Care Undiv (Device) $85.77
- NUCALA (Biological) $83.98
- BREO (Drug) $76.37
- TEZSPIRE (Biological) $74.07
- OFEV (Drug) $64.00
- BEVESPI AEROSPHERE (Drug) $56.29
- Photofrin (Drug) $53.24
- SPIRIVA RESPIMAT (Drug) $50.42
- AIRSUPRA (Drug) $45.45
- TUDORZA PRESSAIR (Drug) $44.92
- PURIFIED CORTROPHIN GEL (Drug) $36.12
- CRE (Device) $35.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.